William D. Waddill, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 8,500 shares at $14.77 ($126K) on 2019-01-11, disclosed to the SEC on 2019-01-11.
Open-market sale of $126k ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |